• Теги
    • избранные теги
    • Компании696
      • Показать ещё
      Разное167
      • Показать ещё
      Международные организации8
      • Показать ещё
      Страны / Регионы109
      • Показать ещё
      Показатели21
      • Показать ещё
      Люди22
      • Показать ещё
      Издания4
      Формат1
      Сферы1
Vertex Pharmaceuticals
28 апреля, 16:15

Vertex (VRTX) Q1 Earnings Top, CF Products Sales Strong

Vertex Pharmaceuticals Incorporated (VRTX) reported first-quarter 2017 earnings per share of 13 cents (including the impact of stock-based compensation expense), which beat the Zacks Consensus Estimate of 4 cents.

Выбор редакции
26 апреля, 17:30

What's in Store for Nivalis (NVLS) this Earnings Season?

Nivalis Therapeutics, Inc. (NVLS) is expected to report first-quarter 2017 results early next month. Last quarter, the company had a positive surprise of 9.09%.

26 апреля, 15:18

Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug

Focus this week remained on Biogen's (BIIB) first quarter results which surpassed expectations.

24 апреля, 17:34

What's in Store for Vertex (VRTX) this Earnings Season?

Vertex Pharmaceuticals, Inc. (VRTX) is scheduled to report first-quarter 2017 results on Apr 27, after the market closes.

18 апреля, 16:30

Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals

Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals

17 апреля, 16:03

5 Toxic Stocks to Shun or Play Short Right Now

Just like picking up stocks with strong growth potential, pinpointing toxic stocks and abandoning them at the right time is the key to protect your portfolio from big losses or make profits by short selling them.

Выбор редакции
17 апреля, 13:47

Vertex Pharmaceuticals stock price target to $128 from $115 at Leerink Partners

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

13 апреля, 21:49

Top Research Reports for Today: MSFT, BLK, NOC

Top Research Reports for Today: MSFT, BLK, NOC

12 апреля, 15:36

TherapeuticsMD Falls on Likely Delay in TX-004HR Approval

Shares of TherapeuticsMD, Inc. (TXMD) have declined almost 25% since Monday when it received a letter from the FDA identifying deficiencies in the new drug application (NDA) for its dyspareunia drug, TX-400HR filed last July

12 апреля, 14:36

Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback

Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.

07 апреля, 16:30

The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics

The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics

Выбор редакции
06 апреля, 16:40

Vertex Pharmaceuticals (VRTX) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Vertex Pharmaceuticals Incorporated (VRTX).

06 апреля, 16:32

3 of the Best & Worst Performing Drug Stocks of Q1

Here is a look at 3 of the best and worst-performing drug stocks in the first quarter of 2017.

05 апреля, 18:20

Amgen Files for Xgeva Label Expansion, To Include Myeloma

Amgen, Inc. (AMGN) recently announced that it has submitted a supplemental Biologics License Application (sBLA) to the FDA to expand the label of its key drug, Xgeva.

05 апреля, 15:59

Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug

Court rulings and patent challenges made headlines in the biotech sector with companies like Acorda (ACOR) and Celgene (CELG) providing updates.

05 апреля, 00:48

5 Stocks that Outperformed the S&P 500 in Q1

First quarter was quite impressive and we have selected five top-ranked stocks that surpassed the S&P 500 index during the period.

04 апреля, 22:34

5 Stocks that Chaperoned Nasdaq to Double-Digit Gains in Q1

The tech-heavy index, Nasdaq, outperformed and recorded a gain of 10% in the first quarter.

04 апреля, 16:19

Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk

A real-world observational study showed that when type 2 diabetes patients on basal insulin switched to Toujeo, it led to a significant reduction in risk of hypoglycemia without compromising blood sugar control

03 апреля, 16:50

AstraZeneca's (AZN) Lung Cancer Drug Gets Full FDA Approval

AstraZeneca plc (AZN) announced that its lung cancer drug, Tagrisso has received full approval from the FDA.